Invention Grant
- Patent Title: Medicaments and methods for treating mesothelioma
-
Application No.: US14681362Application Date: 2015-04-08
-
Publication No.: US09636395B2Publication Date: 2017-05-02
- Inventor: Anne Gauvrit , Frédéric Tangy , Marc Gregoire
- Applicant: INSTITUT PASTEUR , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Applicant Address: FR Paris FR Paris
- Assignee: INSTITUT PASTEUR,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: INSTITUT PASTEUR,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: FR Paris FR Paris
- Agency: Michael Best & Friedrich LLP
- Priority: EP07291232 20071010
- Main IPC: C12N7/00
- IPC: C12N7/00 ; A61K39/165 ; A61K39/12 ; C12N5/0784 ; A61K39/00
Abstract:
The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.
Public/Granted literature
- US20150209423A1 MEDICAMENTS AND METHODS FOR TREATING MESOTHELIOMA Public/Granted day:2015-07-30
Information query
